NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDAlemtuzumab Lemtrada® Malignant disease and immunosuppression, Anti-lymphocyte monoclonal antibodies, 08.02.03
REDDinutuximab Qarziba® Malignant disease and immunosuppression, Anti-lymphocyte monoclonal antibodies, 08.02.03
REDGemtuzumab Mylotarg®
(Infusion) 		Malignant disease and immunosuppression, Anti-lymphocyte monoclonal antibodies, 08.02.03
REDInotuzumab Besponsa®
(Infusion) 		Malignant disease and immunosuppression, Anti-lymphocyte monoclonal antibodies, 08.02.03
REDObinutuzumab Gazyvaro ® Malignant disease and immunosuppression, Anti-lymphocyte monoclonal antibodies, 08.02.03
REDOfatumumab Arzerra® Malignant disease and immunosuppression, Anti-lymphocyte monoclonal antibodies, 08.02.03
REDRituximab Rixathon®Truxima® Malignant disease and immunosuppression, Anti-lymphocyte monoclonal antibodies, 08.02.03
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Alemtuzumab Alemtuzumab Immune System, Immunosuppressants, Monoclonal Antibodies
Immune System Disorders And Transplantation, Multiple Sclerosis
Amivantamab Amivantamab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Atezolizumab  Atezolizumab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Avelumab  Avelumab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
BasiliximabBasiliximab Immune System, Immunosuppressants, Monoclonal Antibodies
Immune System Disorders And Transplantation
Belantamab  Belantamab Mafodotin [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Belimumab Belimumab Immune System, Immunosuppressants, Monoclonal Antibodies
Immune System Disorders And Transplantation
Benralizumab Benralizumab Respiratory System, Immunosuppressants, Monoclonal Antibodies
Airways Disease, Obstructive
Bevacizumab Bevacizumab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Blinatumomab Blinatumomab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Brentuximab  Brentuximab Vedotin [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
BurosumabBurosumab Nutrition And Metabolic Disorders, Drugs Affecting Bone Structure And Mineralisation, Monoclonal Antibodies
Fluid And Electrolyte Imbalances, Phosphate Imbalance, Hypophosphataemia
CanakinumabCanakinumab Immune System, Immunosuppressants, Monoclonal Antibodies
Immune System Disorders And Transplantation
CanakinumabCanakinumab Musculoskeletal System, Immunosuppressants, Monoclonal Antibodies
Hyperuricaemia And Gout
Cemiplimab  Cemiplimab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Cetuximab Cetuximab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Daratumumab  Daratumumab Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Denosumab  Denosumab Endocrine System, Drugs Affecting Bone Structure And Mineralisation, Monoclonal Antibodies
Bone Metabolism Disorders
Denosumab  Denosumab Malignant Disease, Drugs Affecting Bone Structure And Mineralisation, Monoclonal Antibodies
Secondary Bone Metastases And Hypercalcaemia
Digoxin-Specific Digoxin-Specific Antibody Poisoning, Antidotes And Chelators, Antibodies
Drug Toxicity, Digoxin Toxicity
Dinutuximab Dinutuximab Beta [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
DonanemabDonanemab Nervous System, Amyloid Beta-Directed Antibodies
Dementia
Dostarlimab Dostarlimab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Durvalumab Durvalumab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Elotuzumab Elotuzumab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Elranatamab Elranatamab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Enfortumab  Enfortumab Vedotin [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Epcoritamab Epcoritamab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Gemtuzumab Gemtuzumab Ozogamicin [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Glofitamab Glofitamab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Inotuzumab Inotuzumab Ozogamicin [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Ipilimumab Ipilimumab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Isatuximab Isatuximab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
LecanemabLecanemab Nervous System, Amyloid Beta-Directed Antibodies
Dementia
Loncastuximab  Loncastuximab Tesirine [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Mepolizumab Mepolizumab Respiratory System, Immunosuppressants, Monoclonal Antibodies
Airways Disease, Obstructive
Mirvetuximab Mirvetuximab Soravtansine [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Mogamulizumab Mogamulizumab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Mosunetuzumab Mosunetuzumab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Natalizumab Natalizumab Immune System, Immunosuppressants, Monoclonal Antibodies
Immune System Disorders And Transplantation, Multiple Sclerosis
Nivolumab  Nivolumab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Nivolumab  Nivolumab With Relatlimab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Obinutuzumab Obinutuzumab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Ocrelizumab Ocrelizumab Immune System, Immunosuppressants, Monoclonal Antibodies
Immune System Disorders And Transplantation, Multiple Sclerosis
Ofatumumab Ofatumumab Immune System, Immunosuppressants, Monoclonal Antibodies
Immune System Disorders And Transplantation, Multiple Sclerosis
Omalizumab  Omalizumab Respiratory System, Immunosuppressants, Monoclonal Antibodies
Airways Disease, Obstructive
Omalizumab  Omalizumab Skin, Immunosuppressants, Monoclonal Antibodies
Inflammatory Skin Conditions, Urticaria
Palivizumab  Palivizumab Anti-Infective, Drugs For Respiratory Diseases, Monoclonal Antibodies
Viral Infection, Respiratory Syncytial Virus
Panitumumab Panitumumab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Pembrolizumab Pembrolizumab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Pertuzumab Pertuzumab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Pertuzumab Pertuzumab With Trastuzumab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Polatuzumab  Polatuzumab Vedotin [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Ramucirumab Ramucirumab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Reslizumab Reslizumab Respiratory System, Immunosuppressants, Monoclonal Antibodies
Airways Disease, Obstructive
Rituximab  Rituximab Immune System, Antineoplastic Drugs, Monoclonal Antibodies
Immune System Disorders And Transplantation
Rituximab  Rituximab Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Rituximab  Rituximab Musculoskeletal System, Antineoplastic Drugs, Monoclonal Antibodies
Arthritis
Romosozumab Romosozumab Endocrine System, Drugs Affecting Bone Structure And Mineralisation, Monoclonal Antibodies
Bone Metabolism Disorders
RozanolixizumabRozanolixizumab Musculoskeletal System, Immunosuppressants, Monoclonal Antibodies
Neuromuscular Disorders, Myasthenia Gravis And Lambert-Eaton Myasthenic Syndrome
Sacituzumab  Sacituzumab Govitecan [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
SiltuximabSiltuximab Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Sotrovimab  Sotrovimab Anti-Infective, Antivirals, SARS-Cov-2 Neutralising Monoclonal Antibodies
Viral Infection, Coronavirus
Tafasitamab Tafasitamab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Talquetamab Talquetamab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Teclistamab Teclistamab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Tezepelumab Tezepelumab Respiratory System, Immunosuppressants, Monoclonal Antibodies
Airways Disease, Obstructive
Trastuzumab Trastuzumab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Trastuzumab Trastuzumab Deruxtecan [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Trastuzumab Trastuzumab Emtansine [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Tremelimumab Tremelimumab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Ublituximab Ublituximab Immune System, Immunosuppressants, Monoclonal Antibodies
Immune System Disorders And Transplantation, Multiple Sclerosis
Vedolizumab Vedolizumab Gastro-Intestinal System, Immunosuppressants, Monoclonal Antibodies
Chronic Bowel Disorders, Inflammatory Bowel Disease
Zolbetuximab Zolbetuximab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.